Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2006 Mar;98(3):415–419.

Primary prevention of type-2 diabetes in developing countries.

Samuel Dagogo-Jack 1
PMCID: PMC2576111  PMID: 16573308

Abstract

Although diabetes is now a worldwide epidemic, the rate of increase in its prevalence in developing countries is alarming. By the year 2025, more than three-quarters of all persons with diabetes will reside in developing countries. India and China are leading this surge in diabetes, and sub-Saharan Africa is currently at a lower prevalence rate. However, the estimated increase is substantial among African descendants in the Americas, West Indies and throughout the diaspora. There are compelling reasons why aggressive efforts must be directed toward primary prevention of diabetes in developing countries. Once diabetes develops, the cost of caring for patients is prohibitive. Poorly managed diabetes leads to several complications (e.g., end-stage renal failure, blindness, amputation and heart disease) that many developing countries are ill equipped to tackle. In landmark trials, lifestyle modification approaches are more efficacious than expensive medications in the prevention of diabetes. This is fortunate because lifestyle modification can be implemented locally, whereas medications often need to be imported at high cost. The first task is the education of policymakers on the urgent need for timely action to prevent the looming epidemic of diabetes. Once governments become convinced of its critical value, the translation of diabetes prevention through dietary modification and increased physical activity would require careful planning, extensive piloting and creativity in the allocation of scant resources. External support, foreign aid, debt forgiveness and other forms of creative financing will almost certainly be needed to implement widespread diabetes prevention programs in developing countries.

Full text

PDF
415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dagogo-Jack Samuel. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J Natl Med Assoc. 2003 Sep;95(9):774, 779-89. [PMC free article] [PubMed] [Google Scholar]
  2. Deeb L. C., Tan M. H., Alberti K. G. Insulin availability among International Diabetes Federation member associations. Report of the Task Force on Insulin Distribution. Diabetes Care. 1994 Mar;17(3):220–223. doi: 10.2337/diacare.17.3.220. [DOI] [PubMed] [Google Scholar]
  3. Diabetes Prevention Program Research Group Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care. 2003 Sep;26(9):2518–2523. doi: 10.2337/diacare.26.9.2518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Haffner S. M., D'Agostino R., Saad M. F., Rewers M., Mykkänen L., Selby J., Howard G., Savage P. J., Hamman R. F., Wagenknecht L. E. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996 Jun;45(6):742–748. doi: 10.2337/diab.45.6.742. [DOI] [PubMed] [Google Scholar]
  5. Hernan William H., Brandle Michael, Zhang Ping, Williamson David F., Matulik Margaret J., Ratner Robert E., Lachin John M., Engelgau Michael M., Diabetes Prevention Program Research Group Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2003 Jan;26(1):36–47. doi: 10.2337/diacare.26.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kaufman Francine Ratner. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab. 2002 May;15 (Suppl 2):737–744. doi: 10.1515/JPEM.2002.15.s2.737. [DOI] [PubMed] [Google Scholar]
  7. King H., Aubert R. E., Herman W. H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998 Sep;21(9):1414–1431. doi: 10.2337/diacare.21.9.1414. [DOI] [PubMed] [Google Scholar]
  8. Knowler William C., Barrett-Connor Elizabeth, Fowler Sarah E., Hamman Richard F., Lachin John M., Walker Elizabeth A., Nathan David M., Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393–403. doi: 10.1056/NEJMoa012512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mbanya J. C., Cruickshank J. K., Forrester T., Balkau B., Ngogang J. Y., Riste L., Forhan A., Anderson N. M., Bennett F., Wilks R. Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care. 1999 Mar;22(3):434–440. doi: 10.2337/diacare.22.3.434. [DOI] [PubMed] [Google Scholar]
  10. Moneva M. H., Dagogo-Jack S. Multiple drug targets in the management of type 2 diabetes. Curr Drug Targets. 2002 Jun;3(3):203–221. doi: 10.2174/1389450023347803. [DOI] [PubMed] [Google Scholar]
  11. Osei K., Schuster D. P., Owusu S. K., Amoah A. G. Race and ethnicity determine serum insulin and C-peptide concentrations and hepatic insulin extraction and insulin clearance: comparative studies of three populations of West African ancestry and white Americans. Metabolism. 1997 Jan;46(1):53–58. doi: 10.1016/s0026-0495(97)90167-0. [DOI] [PubMed] [Google Scholar]
  12. Pan X. R., Li G. W., Hu Y. H., Wang J. X., Yang W. Y., An Z. X., Hu Z. X., Lin J., Xiao J. Z., Cao H. B. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997 Apr;20(4):537–544. doi: 10.2337/diacare.20.4.537. [DOI] [PubMed] [Google Scholar]
  13. Pettitt D. J., Aleck K. A., Baird H. R., Carraher M. J., Bennett P. H., Knowler W. C. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes. 1988 May;37(5):622–628. doi: 10.2337/diab.37.5.622. [DOI] [PubMed] [Google Scholar]
  14. Prentice A. M., Moore S. E. Early programming of adult diseases in resource poor countries. Arch Dis Child. 2005 Apr;90(4):429–432. doi: 10.1136/adc.2004.059030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rosenbloom A. L., Joe J. R., Young R. S., Winter W. E. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999 Feb;22(2):345–354. doi: 10.2337/diacare.22.2.345. [DOI] [PubMed] [Google Scholar]
  16. Tuomilehto J., Lindström J., Eriksson J. G., Valle T. T., Hämäläinen H., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., Laakso M., Louheranta A., Rastas M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 May 3;344(18):1343–1350. doi: 10.1056/NEJM200105033441801. [DOI] [PubMed] [Google Scholar]
  17. Vaag A., Henriksen J. E., Madsbad S., Holm N., Beck-Nielsen H. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest. 1995 Feb;95(2):690–698. doi: 10.1172/JCI117715. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES